Search clinical trials for: Hormonal Intake, Breast Cancer Risk, Demographic Factors
Total 137633 results
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
UTC Therapeutics Inc.Peking University Cancer Hospital & InstituteRecruitingColorectal Cancer | Pancreatic Cancer | Rectal Cancer | Malignant Mesothelioma | Bile Duct Cancer | Breast Cancer Female | Ovary CancerChina
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
National Cancer Institute (NCI)RecruitingBreast Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Gastrointestinal Cancer | Genitourinary Cancer | Metastatic Solid CancersUnited States
-
Guangzhou Lupeng Pharmaceutical Company LTD.RecruitingB-cell Non-Hodgkin LymphomaChina
-
Children's Oncology GroupNot yet recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Juvenile Myelomonocytic Leukemia | Refractory Juvenile Myelomonocytic Leukemia
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteNot yet recruitingBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingTriple Negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Virginia G. KaklamaniNot yet recruitingTriple Negative Breast Cancer | DNA Damage Repair DeficiencyUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGilead SciencesNot yet recruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
OnKure, Inc.RecruitingBreast Cancer | Advanced CancerUnited States, Spain
-
Second Affiliated Hospital of Soochow UniversityRecruiting
-
SOLTI Breast Cancer Research GroupNot yet recruitingBreast Cancer Stage IVSpain
-
Grupo Espanol de Tumores NeuroendocrinosGilead Sciences; MFARNot yet recruitingDifferentiated Thyroid Cancer | Anaplastic Thyroid CancerSpain
-
Sun Yat-sen UniversityNot yet recruiting
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Australia, Italy, Malaysia, Turkey
-
N.N. Petrov National Medical Research Center of...RecruitingMelanoma | Lung Cancer | Pancreas Cancer | Refractory Cancer | Colorectal Cancer Recurrent | RAS Mutation | Ras (Kras or Nras) Gene MutationRussian Federation
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingBreast Cancer | Triple Negative Breast Cancer
-
RemeGen Co., Ltd.Recruiting
-
Region Örebro CountyMid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala,...Not yet recruiting
-
National Taiwan University HospitalDebiopharm International SA; Ministry of Health and WelfareNot yet recruitingTriple Negative Breast Cancer | Premenopausal Breast Cancer
-
Stichting Hemato-Oncologie voor Volwassenen NederlandUMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular...Not yet recruitingDLBCL - Diffuse Large B Cell LymphomaNetherlands
-
Fudan UniversityNot yet recruiting
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Changhai HospitalNot yet recruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
University of California, San DiegoNational Cancer Institute (NCI); University of California, Los AngelesNot yet recruitingPancreatic CancerUnited States
-
Brigham and Women's HospitalNot yet recruitingMuscle Invasive Bladder Urothelial CarcinomaUnited States
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical HyperplasiaUnited States
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated...RecruitingAdvanced Thyroid Cancer Patients Who Received Target TherapyChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Institut CurieZionexaRecruiting
-
University Health Network, TorontoCanadian Cancer Society (CCS); Young Adult Cancer CanadaNot yet recruitingSarcoma | Lymphoma | Breast Cancer | Testicular Cancer
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
GenmabAbbVieRecruitingFollicular Lymphoma (FL)United States, Puerto Rico, Australia, Israel, Korea, Republic of, Romania, Serbia, Spain, Taiwan
-
Rutgers, The State University of New JerseyRecruitingBreast Cancer | Colorectal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Prostate Cancer | Endometrial Cancer | Pancreas Cancer | Peritoneal CancerUnited States
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
RemeGen Co., Ltd.Recruiting
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
MedSIRHoffmann-La RocheNot yet recruiting
-
National Cancer Institute (NCI)Recruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Recruiting
-
National Cancer Institute (NCI)Not yet recruitingSquamous Cell Carcinoma of the Penis | Renal Medullary Carcinoma | Squamous Cell Carcinoma of the Bladder | Small Cell Carcinoma of the Bladder | Small Cell Carcinoma of the Urinary Tract | Squamous Cell Carcinoma of the Urinary Tract | Primary Adenocarcinoma of the Bladder | Primary Adenocarcinoma...United States